Article Details
Retrieved on: 2022-10-28 07:53:35
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Renaissance Technologies LLC now owns 69,700 shares of the biopharmaceutical company's stock valued at $88,000 after acquiring an additional 47,700 ...
Article found on: www.etfdailynews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here